EPC 2018 Updates in Pulmonary Disease

September 6, 2018 to September 9, 2018

Didactic lectures allow speakers to provide evidence based medical recommendations, updates and expert opinion.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and Eastern Pulmonary Conference (EPC).  The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commerical Support
This activity is not supported by medical education grants.

Target Audience

Practicing allergists and allied healthcare providers in the field of allergy, asthma and immunology.

Learning Objectives

  • Discuss the role of viruses in the pathogenesis of asthma
  • Outline and discuss the different phenotypic expressions of asthma such obesity and asthma, occupational asthma and severe uncontrolled asthma
  • Describe and discuss the use of new modalities in asthma treatment including biologic treatments and bronchial thermoplasty
  • Prioritize and select delivery devices for your patients according to their needs and abilities to use them
  • Apply evidence-based principles of weaning to patients receiving mechanical ventilation
  • Propose and order an evidence-based treatment plan for patient with COPD including a judicious use of inhaled corticosteroids when indicated
  • Discuss the epidemiology, burden of illness and pathophysiology of pulmonary embolism and best approaches to treatment including newer oral anticoagulants (NOACs)
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no financial relationships to disclose must also inform the learners that no financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. 

All identified conflicts of interest have been resolved.

Sidney Braman, MD – (Planner, Moderator, Speaker)
Consultant – Sunovion 
Speaker – Genentech
Independent Contractor – AstraZeneca

Mario Castro, MD – (Speaker)
Consultant – Boston Scientific, Genentech, Teva, Nuvaira, Aviragen, 4D Pharma, VIDA, Neutronic, Mallincrodt, Theravance 
Speaker – Boston Scientific, Genentech, Teva, AstraZeneca, 
Independent Contractor – Sanofi, Boehringer Ingelheim, AstraZeneca, Chiesi, Novartis

Geoffrey Chupp, MD – (Speaker)
Speaker – AstraZeneca, Genentech, Boston Scientific, Circassia
Advisory Board – AstraZeneca, GlaxoSmithKline, Teva

William Corrao, MD – (Moderator, Speaker)
Speaker – Boehringer Ingelheim
Advisory Board – GlaxoSmithKline

James Lamberti, MD – (Speaker)
Speaker – Janssen, Portola, Sunovion, Boehringer Ingelheim
Advisory Board – GlaxoSmithKline, Boehringer Ingelheim


Donald Mahler, MD – (Speaker)
Consultant – Boehringer Ingelheim
Speaker – Boehringer Ingelheim, Sunovion
Advisory Board – Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Sunovion, Theravance

Barry Make, MD – (Speaker)
Consultant – AstraZeneca, GlaxoSmithKline, Circassia, Verona, Third Pole 
Advisory Board – Sunovion

Maria Padilla, MD – (Speaker)
Consultant – Boehringer Ingelheim
Speaker – Genentech

Rey Panettieri Jr., MD – (Planner, Moderator, Speaker)
Speaker – AstraZeneca, MedImmune, Boehringer Ingelheim, Teva 
Advisory Board – AstraZeneca, MedImmune, Novartis, Boehringer Ingelheim,
Independent Contractor – AstraZeneca, Sanofi, MedImmune, Theratrophix, OncoArendi, Vertex, Bristol Myers Squibb, RIFM, Gilead, Genentech

Mary Salvatore, MD – (Speaker)
Speaker – Genentech

Russell Settipane, MD – (Planner, Moderator, Speaker, Reviewer)
Speaker – ALK, AstraZeneca, Boehringer Ingelheim, Circassia, Genentech, Mylan, Pharming, Regeneron, Sanofi, Shire, Sunovion, Teva 
Advisory Board – ALK, AstraZeneca, DBV Technologies, Genentech, Regeneron, Sanofi, Teva, Alk, Circassia, Sanofi/Regeneron, CSL Behring
Independent Contractor – AstraZeneca, Chiesi, Genentech, GlaxoSmithKline, Merck, Novartis, Teva


The following have no relevant financial relationships to disclose:
Curtis Sessler, MD – (Speaker)
Lawrence Mohr, MD – (Speaker)
Marilyn Glassberg, MD – (Speaker)
 

Course summary
Available credit: 
  • 14.25 AMA PRA Category 1 Credit™
  • 14.25 Attendance
Course opens: 
09/06/2018
Course expires: 
09/09/2020
Event starts: 
09/06/2018 - 3:00pm
Event ends: 
09/09/2018 - 9:30am
Cost:
$0.00
Rating: 
0

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and Eastern Pulmonary Conference (EPC).  The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 14.25 AMA PRA Category 1 Credit™
  • 14.25 Attendance

Accreditation Period

Course opens: 
09/06/2018
Course expires: 
09/09/2020

Price

Cost:
$0.00
Please login or create an account to take this course.